Curative Biotechnology, Inc. (CUBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0087
+0.0008 (10.13%)
Mar 6, 2026, 2:35 PM EST
Curative Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.03 | 0.02 | 0.06 | 0.06 | 0.67 | 0.16 | Upgrade
|
| Cash & Short-Term Investments | 0.03 | 0.02 | 0.06 | 0.06 | 0.67 | 0.16 | Upgrade
|
| Cash Growth | -47.60% | -65.36% | -3.87% | -91.25% | 317.33% | - | Upgrade
|
| Other Receivables | - | - | 0.12 | - | 0.03 | - | Upgrade
|
| Receivables | - | - | 0.12 | - | 0.03 | - | Upgrade
|
| Prepaid Expenses | 0.09 | 0.16 | 0.43 | - | 0.06 | 1.9 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.07 | Upgrade
|
| Total Current Assets | 0.12 | 0.18 | 0.6 | 0.06 | 0.75 | 2.13 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Other Intangible Assets | 1.33 | 1.35 | 1.42 | 1.51 | 1.56 | 0.14 | Upgrade
|
| Long-Term Deferred Charges | 0.69 | 0.66 | 0.57 | 0.49 | 0.09 | - | Upgrade
|
| Total Assets | 2.14 | 2.19 | 2.6 | 2.06 | 2.41 | 2.27 | Upgrade
|
| Accounts Payable | 4.54 | 4.13 | 3.49 | 3.43 | 0.73 | 0.1 | Upgrade
|
| Short-Term Debt | 3.48 | 2.94 | 2.26 | 1.12 | - | 0.56 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.04 | 0 | 0.01 | Upgrade
|
| Total Current Liabilities | 8.02 | 7.06 | 5.75 | 4.6 | 0.73 | 0.66 | Upgrade
|
| Total Liabilities | 8.02 | 7.06 | 5.75 | 4.6 | 0.73 | 0.66 | Upgrade
|
| Common Stock | 0.11 | 0.09 | 0.09 | 0.06 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 38.5 | 36.79 | 34.99 | 29.81 | 10.56 | 3.58 | Upgrade
|
| Retained Earnings | -44.48 | -41.76 | -38.23 | -32.41 | -26.92 | -8.1 | Upgrade
|
| Total Common Equity | -5.88 | -4.88 | -3.15 | -2.54 | -16.36 | -4.52 | Upgrade
|
| Shareholders' Equity | -5.88 | -4.87 | -3.14 | -2.54 | 1.68 | 1.61 | Upgrade
|
| Total Liabilities & Equity | 2.14 | 2.19 | 2.6 | 2.06 | 2.41 | 2.27 | Upgrade
|
| Total Debt | 3.48 | 2.94 | 2.26 | 1.12 | - | 0.56 | Upgrade
|
| Net Cash (Debt) | -3.44 | -2.92 | -2.2 | -1.07 | 0.67 | -0.4 | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| Filing Date Shares Outstanding | 1,073 | 919.26 | 903.26 | 572.01 | 571.65 | 544.79 | Upgrade
|
| Total Common Shares Outstanding | 1,073 | 919.26 | 903.26 | 572.01 | 570.65 | 333 | Upgrade
|
| Working Capital | -7.9 | -6.88 | -5.14 | -4.54 | 0.02 | 1.47 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | -0.00 | -0.00 | -0.03 | -0.01 | Upgrade
|
| Tangible Book Value | -7.21 | -6.22 | -4.57 | -4.05 | -17.92 | -4.66 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.